Clinical Trial Update: Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD) [EARLY_Phase 1]

View source ↗

Summary

Terminated early-phase 1 trial investigating mitochondrial-derived reactive oxygen species and cardiovascular health in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Chronic Obstructive Pulmonary Disease | EARLY_Phase 1 | Status: TERMINATED